ConductScience.org, home

Paper7207618

Transforming genes of carcinomas and neuroblastomas introduced into mouse fibroblasts.

Shih C and 3 others. Nature, 1981. Cited by 745 papers, by iCite.

Cite this record

ConductScience Library. Transforming genes of carcinomas and neuroblastomas introduced into mouse fibroblasts. Papers, record 7207618. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7207618

Download JSON
Cell line
EJ-6-2-Bam-6a1 paper
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Transforming genes of carcinomas and neuroblastomas introduced into mouse fibroblasts.
PubMed
Journal
Nature
PubMed
Year
1981
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
745
iCite
Relative citation ratio, by iCite
14.3
iCite
Revised in PubMed
2021-01-08
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Shih CC
2Padhy LCL C
3Murray MM
4Weinberg RAR A

Source PubMed

Download CSV of authors

Topics19

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Cell Transformation, NeoplasticMajor topic
DNA, NeoplasmMajor topic
GenesMajor topic
Animals
Carcinoma
Cells, Cultured
Fibroblasts
Glioma
Humans
Lung Neoplasms
Mice
Neoplasms, Experimental
Neuroblastoma
Rabbits
Rats
Species Specificity
Transfection
Transformation, Genetic
Urinary Bladder Neoplasms

Source PubMed

Download CSV of topics

Grants3

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
CA14051NCI NIH HHSUnited StatesP01CA014051PubMed and NIHNIH RePORTER
CA26717NCI NIH HHSUnited StatesP01CA026717PubMed and NIHNIH RePORTER
P30CA014051NIHNIH RePORTER

Download CSV of grants

Cited by198

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 745 citations.

PMIDTitleJournalYearIn PapersSource
42165909Current evidence on the cell of origin of meningiomas disputes the arachnoid cap cell dogma.Acta Neurochir (Wien)2026https://conductscience.org/library/papers/42165909PubMed
42105364Mechanistic insights on spatiotemporal control of Ras-signaling.Biol Chem2026https://conductscience.org/library/papers/42105364PubMed
40862761HER2/neu as a Signaling and Therapeutic Marker in Uterine Serous Carcinoma.Cells2025https://conductscience.org/library/papers/40862761PubMed
39638567"Undruggable KRAS": druggable after all.Genes Dev2025https://conductscience.org/library/papers/39638567PubMed
39455281Molecular and cellular dynamics of squamous cell carcinomas across tissues.Genes Dev2025https://conductscience.org/library/papers/39455281PubMed
39020378HER3 receptor and its role in the therapeutic management of metastatic breast cancer.J Transl Med2024https://conductscience.org/library/papers/39020378PubMed
38539456HER2-Positive Early Breast Cancer: Time for Ultimate De-Escalation?Cancers (Basel)2024https://conductscience.org/library/papers/38539456PubMed
37306902Transforming Diagnosis and Therapeutics Using Cancer Genomics.Cancer Treat Res2023https://conductscience.org/library/papers/37306902PubMed
37110218Deregulated Metabolic Pathways in Ovarian Cancer: Cause and Consequence.Metabolites2023https://conductscience.org/library/papers/37110218PubMed
36890849Application of Immunohistochemistry in Clinical Practices as a Standardized Assay for Breast Cancer.Acta Histochem Cytochem2023https://conductscience.org/library/papers/36890849PubMed
36617643Emerging Therapies for Breast Cancer.Cold Spring Harb Perspect Med2023https://conductscience.org/library/papers/36617643PubMed
36512199Peto's paradox revisited: black box vs mechanistic approaches to understanding the roles of mutations and promoting factors in cancer.Eur J Epidemiol2023https://conductscience.org/library/papers/36512199PubMed
36344672Targeting HER2-positive breast cancer: advances and future directions.Nat Rev Drug Discov2023https://conductscience.org/library/papers/36344672PubMed
36165721HER2 and HER3 as Therapeutic Targets in Head and Neck Cancer.Cancer J2022https://conductscience.org/library/papers/36165721PubMed
35731927Inactivating Amplified HER2: Challenges, Dilemmas, and Future Directions.Cancer Res2022https://conductscience.org/library/papers/35731927PubMed
35701396Identification, discrimination and heterogeneity of fibroblasts.Nat Commun2022https://conductscience.org/library/papers/35701396PubMed
35409064Small-Molecule RAS Inhibitors as Anticancer Agents: Discovery, Development, and Mechanistic Studies.Int J Mol Sci2022https://conductscience.org/library/papers/35409064PubMed
35251632Breast microcalcifications: Past, present and future (Review).Mol Clin Oncol2022https://conductscience.org/library/papers/35251632PubMed
35045886The path to the clinic: a comprehensive review on direct KRASG12C inhibitors.J Exp Clin Cancer Res2022https://conductscience.org/library/papers/35045886PubMed
34946546Emerging Therapeutic Agents for Colorectal Cancer.Molecules2021https://conductscience.org/library/papers/34946546PubMed

See all 198 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/7207618

GET https://conductscience.org/api/papers/v1/7207618/cited_by?page=2